What is the recommended dosing for enalapril (Angiotensin-Converting Enzyme (ACE) inhibitor) in patients with hypertension or heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing for Enalapril in Hypertension and Heart Failure

For patients with hypertension, enalapril should be initiated at 5 mg once daily and titrated to 10-40 mg daily (single or divided doses) based on blood pressure response. For heart failure patients, start with 2.5 mg twice daily and titrate up to 10-20 mg twice daily as tolerated. 1, 2

Dosing in Hypertension

  • Initial dose: 5 mg once daily for patients not on diuretics 2
  • Initial dose with concurrent diuretic therapy: 2.5 mg once daily under medical supervision for at least two hours (if diuretic cannot be discontinued 2-3 days before starting enalapril) 2
  • Maintenance dose: 10-40 mg daily, given as a single dose or divided into two doses 2
  • Dose adjustment: If blood pressure control diminishes toward the end of the dosing interval, consider twice daily administration or dose increase 2
  • Target systolic blood pressure: <130 mmHg in patients with hypertension, particularly those at increased cardiovascular risk 1

Dosing in Heart Failure

  • Initial dose: 2.5 mg twice daily 1, 2
  • Titration: Gradually increase dose over a period of a few days to weeks as tolerated 2
  • Target dose: 10-20 mg twice daily (maximum daily dose of 40 mg in clinical trials) 1, 2
  • Minimum effective dose: At least 50% of target dose (5-10 mg twice daily) should be achieved for clinical benefit 1

Special Populations

Renal Impairment

  • Hypertension with renal impairment:

    • Normal to mild impairment (CrCl >30 mL/min): Standard dosing 2
    • Moderate to severe impairment (CrCl ≤30 mL/min): Initial dose 2.5 mg once daily, maximum 40 mg daily 2
  • Heart failure with renal impairment:

    • Serum creatinine >1.6 mg/dL: Start with 2.5 mg daily under close medical supervision 2
    • Titrate cautiously to 2.5 mg twice daily, then 5 mg twice daily as tolerated 2

Hyponatremia

  • For heart failure patients with hyponatremia (serum sodium <130 mEq/L): Initial dose 2.5 mg daily under close medical supervision 2

Monitoring and Dose Adjustment

  • After initial dose, observe patient under medical supervision for at least 2 hours and until blood pressure stabilizes for an additional hour 2
  • Monitor blood chemistry (urea, creatinine, potassium) and blood pressure regularly 1
  • An increase in creatinine of up to 50% above baseline or to 3 mg/dL (whichever is greater) is acceptable 1
  • If excessive increases in creatinine or potassium occur, consider reducing diuretic dose (if no signs of congestion) or discontinuing nephrotoxic drugs 1

Common Pitfalls and Precautions

  • First-dose hypotension: More common in volume-depleted patients (e.g., those on high-dose diuretics). If possible, discontinue diuretic 2-3 days before starting enalapril 2
  • Hyperkalemia risk: Avoid concurrent use with potassium supplements, potassium-sparing diuretics, or potassium salt substitutes unless specifically indicated 2
  • Underdosing: Many patients fail to achieve target doses in clinical practice. Remember that some ACE inhibitor is better than none - aim for at least 50% of target dose 1
  • Cough: ACE inhibitor-induced cough rarely requires discontinuation. If troublesome, consider switching to an angiotensin receptor blocker 1
  • Drug interactions: Avoid NSAIDs and COX-2 inhibitors when possible as they may reduce enalapril's effectiveness and increase renal risk 1

Enalapril has demonstrated significant benefits in reducing mortality and hospitalizations in heart failure patients and effectively controlling blood pressure in hypertensive patients when properly dosed and monitored 1, 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.